January 24, 2019
Shionogi said on January 23 that it has entered into a joint research agreement with PeptiDream, a spin-out of the University of Tokyo, for the discovery and development of multiple peptide drug-conjugates (PDCs) including cargo peptides to improve the delivery...read more